Abstract
Tisotumab vedotin-tftv (TIVDAK (R)), a tissue factor-directed antibody-drug conjugate, is a valuable option for the treatment of adult patients with r......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
